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phytochemical investigations. Aromatic compounds [3] [4] [5] have been isolated from this genus. These secondary metabolites exhibited diverse significant biological activities [6] [7] [8] [9] [10] . C. petersiana Bolle is a tree commonly growing up to 12 m high on sandy soils and at altitudes of up to 1050 m above sea level. In Southern Africa, the leaf is used as a febrifuge and as a cure for skin diseases [11] . Previous investigations of this species led to the isolation of diterpenes [11] and flavonoids [12] . As part of our contribution to the phytochemical, chemotaxonomic and biological survey of the genus Cassia, we carried out an investigation of the CH 2 Cl 2 -MeOH (1:1) extract of the leaves of C. petersiana, a species from Cameroon, and we report herein the isolation and structure elucidation of two new and two known compounds. These secondary metabolites were also evaluated for their antitumor and immunostimulatory activity.
Fractionation by column chromatography of the CH 2 Cl 2 -MeOH (1:1) extract of the leaves of C. petersiana on silica gel and Sephadex LH-20 yielded four compounds, two new chromones (1, 2), and the known compounds glyceryl-1-hexacosanoate [13] and sistosterol-3-O-β-D-glucoside [14] . 3 COH]. The chromone nature of the molecule was deduced from the presence of a peak at m/z 204 in the EIMS, due to the loss of CO and which is characteristic of γ-pyrones [15] . The IR spectrum showed absorption bands at 3385 (OH), 1710 (C=O), 1631 (dienone), and 926 (substituted aromatic ring). The 1 H-NMR spectrum (experimental part) revealed the presence of a 2,5,7-trisubstituted chromone skeleton based on a downfield singlet at δ 5.95 (H-3), two downfield doublets at δ 6.71 (H-6) and δ 6.56 (H-8), two methylene protons at δ 4.20 (2H, s, H-1´) and two methyl groups at δ 2.24 (H-3´) and δ 2.31 (H-1''). These data confirmed that 1 is a chromone derivative by comparison with data previously reported for the same genus [15] . The 13 C NMR data (experimental) showed thirteen carbon signals, and the HMQC and DEPT (90 and 135) led to the assignment of the structure as follows: (i) From the 13 C NMR spectrum it was evident that there are three carbons attached to oxygen [δ 164.2 (C-2), 158.9 (C-5) and 160.9 (C-8a)]. (ii) The 1 H-NMR spectrum of 1 displayed a downfield chelated proton at δ 10.64, which correlated with C-5 in the HMBC spectrum. (iii) The acetonyl moiety and its position were deduced from an intense correlation between H-3´ (δ 2.24) and C-2´ in the HMBC spectrum, and between H-1´ and C-2´ and C-7. (iv) The C-2-Me and the pyrone region of the molecule were assigned from the correlation of H-1´´ (δ 2.35) to C-2 and C-3, and of H-3 (δ 6.00) to C-2, C-1´´ and C-4. (v) H-6 and H-8 were assigned as meta to each other from their coupling constant (2.5 Hz) [16] . The above mentioned correlations suggested the existence of a 2,5,7-trisubstituted chromone skeleton having one hydroxyl group at C-5. The other positions were deduced from the HMBC spectrum. By comparison of our data with those of related compounds [3, 15] , 1 was identified as 7-acetonyl-5-hydroxy-2-methylchromone, which is a new natural product, named petersinone A.
Compound 2 was obtained as a yellow powder, which did not melt before 300 °C. The molecular formula was established as C 13 [3, 16] , 2 was characterised as 5-hydroxyl-2-methyl-7-(propan-2β-ol)-chromone, named petersinone B, which is a new natural product. By application of the Horeau method, the absolute configuration of 2 at C-2´ was assigned as (S) [15, 17] .
Compound 3 was isolated as a white solid, mp 91° C, and shown to be glyceryl-1-hexacosanoate [13, 18] , which has been reported previously after basecatalyzed methanolysis of potato periderm (Solanum tuberosum), but the pure compound was not isolated and no spectral data were given [13] . Spectral assignments are, therefore, presented in the experimental section. The structure of stigmastosterol-3-O-β-D-glucoside (4) was determined from NMR spectral data and comparison with literature information [14] .
Compounds 1a and 2a were obtained by acetylation of 1 and 2, respectively, and characterized from their 1 H and 13 C NMR spectra in combination with DEPT, EIMS and HRFABMS. These spectra suggested that 2 was acetylated at C-2', while 1 was oxidized and acetylated at C-3' during the acetylation reaction. Compounds 1 and 2, on treatment with Jones reagent, afforded 1 ( 1 H NMR). This result confirmed the structures of these compounds. GC-MS analysis, after alkaline methanolysis of 3, identified glycerol and the methylester of hexacosanoic acid as the major products, based on the peaks at m/z 92 and 410, respectively.
The cytotoxic effects of compounds 1-4 were investigated against different solid tumor (Hep-G2, and MCF-7) and leukemia cell lines (1301). Using the MTT metabolic cytotoxicity assay, all compounds except 4 possessed a dose-dependent cytotoxic effect against Hep-G2 cells at relatively high concentrations with similar low slopes. However, 4 was the most cytotoxic compound with the lowest IC 50 value of 82.7 µM ( Figure 1A ). In a parallel experiment with another solid tumor cell line, the tested compounds inhibited the cell viability of MCF-7 cells in a dose dependent manner. The calculated IC 50 values against MCF-7 cells were 112.2 µM, 143.7 µM, 68.1 µM, and 114.3 µM for 1, 2, 3, and 4, respectively ( Figure  1B ). The cytotoxic activity against solid tumor cells suggested that these compounds might possess a similar cytotoxic effect on leukemia cells. Surprisingly, the experiment with leukemia 1301 cells (T-lymphocytes) showed a non-toxic effect, as well as the relative induction of constant lymphocyte growth, irrespective of the concentration ( Figure 1C ). Lymphocyte proliferation produced by compounds 2 and 3 was higher than that of 1 and 4, but a double fold increment in concentration led to a narrow change in the proliferation activity in a range of 115-129% and 125-134% of the control viability, respectively.
The elevated lymphocyte proliferation prompted an investigation into whether the compounds are immunostimulators and produce the same effect on other types of immune cells. Consequently, the alteration in the macrophage proliferation index was monitored using RAW 264.7 cells. Interestingly, the compounds generally increased the macrophage proliferation index. Although compounds 1 and 3 were the highest stimulators of macrophage proliferation in a dose-dependent manner, compounds 2 and 4 showed a peak point of stimulation at 20 µM that then dropped with an increase in concentration, but was still higher than the control. The co-immunoproliferative activity of the compounds on T-lymphocytes and macrophages may be a result of either an induced expression of specific growth factors, such as interleukin-2 for lymphocytes and interleukin-12 for macrophages, or other mechanisms that need to be explored.
Whether the co-immunostimulatory activity of these compounds towards lymphocytes and macrophages arose from activation of their functions was investigated by examining the influence of the tested compounds on NO generation from macrophages. However, the compounds showed no change in NO level, as measured by the Griess reaction. This finding suggested an examination of the effect of these compounds on pre-induced NO, using a mimic inflammation model of LPS-mediated (µNOS) induction of murine macrophages. Surprisingly, compounds 1-4 inhibited the LPS-induced NO inhibition by 80.5%, 89.3%, 82.1%, and 92.1%, respectively, at concentrations of 20 µM, as normalized to the protein content to avoid the interference of the increased macrophage number at that concentration. Since this inhibition could be due to direct NO scavenging, the antioxidant capacity of the tested compounds was investigated using the DPPH assay. DPPH is a stable non-physiological radical, which can provide a relative measure of the antioxidant activity of a tested probe. The DPPH assay showed that most of the compounds possess weak scavenging activity with high SC 50 values compared to the scavenging activity of the wellknown antioxidant ascorbic acid, except in the case of compound 4, which had an effective SC 50 value as low as 36 µM. This antioxidant activity of 4 may be one of the reasons for its strong inhibition of NO.
fact, the DPPH assay of other compounds does not explain the potent inhibition of NO, which may be In fact, the DPPH assay of other compounds does not explain the potent inhibition of NO, which may be due to other mechanisms. In summary, compound 4 has the highest anti-tumor activity against hepatocellular carcinoma, immunoproliferative activity via induction of T-lymphocytes, macrophage proliferation, antiinflammatory activity as indicated by NO inhibition, and antioxidant activity against DPPH. Moreover, compound 3, the most effective cytotoxic compound against breast carcinoma, stimulated a consistent immunoproliferative effect on lymphocytes and macrophages, combined with unexplainable strong NO inhibitory activity. Compound 1 is a promising immunoproliferative agent and may act as an antiinflammatory agent due to its inhibitory activity of NO.
Experimental
1 H, 13 C NMR and 2D spectra were recorded on a JEOL 500 MHz Lambda spectrometer with TMS as an internal standard. EIMS spectra were recorded on a TSQ-70-Triple Stage Quadruple mass spectrometer (70 eV). The IR spectra (CHCl 3 ) were recorded on a Perkin-Elmer FT-IR-spectrometer. Melting points were determined on a Kofler apparatus and are uncorrected. GC-MS (Masslab Trio 1000), column DB5-MS, 60 m, 0.25 mm internal diameter, 0.25 µm film thickness; injector temperature 325°C; initial oven temperature 100°C (5 min), 10°C/min up to 240°C, 3°C/min up to 300°C, and 1°C/min up to 325°C (10 min). 
Extraction and isolation:
The air-dried and powdered leaves of C. petersiana (800 g) were extracted by maceration with CH 2 Cl 2 -MeOH (1:1), (11 L, 72 h) and evaporated under reduced pressure to yield 80 g (10%) of crude extract. Part of this (30 g) was fractionated by silica gel column chromatography (CC) by elution successively with n-hexane-EtOAc and EtOAc-MeOH in a step gradient using different ratios of solvent. Three fractions, A (7 g, 23%), B (11 g, 36%) and C (5.5 g 18%) were collected. Fraction A was purified on a Sephadex LH-20 column (n-hexane-CH 2 Cl 2 -MeOH, 7:4:1) to give 1 (14 mg) and 2 (23 mg, 0.2%). Fraction B was purified on a silica gel column (n-hexane-EtOAc 9:1) to give 3 (11 mg, 0.1%). Compound 4 (500 mg, 9%) was recrystallized with acetone from fraction C.
Acetylation of compounds 1 and 2:
To 2 and 9 mg of 1 and 2, respectively, in pyridine, 0.5 mL Ac 2 O and 0.5 mg of DMAP were added. The mixture was kept at 25°C in a dark room for 18 h. Water was then added and the organic phase extracted three times with 10 mL of CH 2 Cl 2 . Purification on a Sephadex LH-20 column with n-hexane-CH 2 Cl 2 -MeOH (7:4:0.5) gave 1.1 and 8 mg of 1a and 2a, respectively.
Determination of the stereochemistry of 2 by the
Horeau method: To 6 mg of 2 dissolved in 2 mL of anhydrous pyridine, 0.5 mL of 2-phenylbutanoic anhydride was added. The solution was kept at room temperature overnight. Water (5 mL) was added and the mixture allowed to stand for 30 min for complete hydrolysis. 0.1 N NaOH (2 mL) and phenolphthalein (0.5 mg of powder) was added. Benzene (2 mL) was used to remove the organic phase. The aqueous phase was washed with 10 mL of CHCl 3 and 0.2 mL of HCl (1N) was added. Dry benzene (10 mL, three times) was used to extract the organic compound. Removal of the solvent gave 4 mg of material, which had a positive optical rotation.
Oxidation of compounds 1 and 2:
To 1 mg each of 1 and 2 in 5 mL Et 2 O was added 2 mL Jones reagent prepared by dissolving 2.3 mg of CrO 3 in 1 mL H 2 SO 4 , diluted to 10 mL with water. The mixture was stirred for 3 min. before water was added and the compound extracted with CH 2 Cl 2 .
Alkaline hydrolysis of compound 3: To 5 mL of 15 mmol.L -1 NaOCH 3 , prepared by dissolving metallic sodium in dry methanol, 2 mg of 3 was added. The mixture was kept under reflux for 1h, before water was added and the organic compound extracted with CH 2 Cl 2 . The mixture was analyzed by GC-MS. 1H, s, H-3), 4.11 (2H, s,  H-1'), 2.24 (3H, s, H-3'), 2.31 (3H, s, H-1'' ). 13 
5-Hydroxy-7-(2´-acetoxypropyl)-2-methylchromone (2a)
[α] 
Biological activities
Cell culture: The cell lines 1301 (human lymphoblastic leukemia), Hep G2 (human hepatocarcinoma), MCF-7 (human breast adenocarcinoma) and RAW 264.7 (raw murine macrophage) were purchased from American Type Culture Collection (Rockville, MD). Cells were routinely cultured in DMEM (Dulbeco's Modified Eagle's Medium), except RAW 264.7 cells, which were grown in RPMI-1640 medium. Media were supplemented with 10% fetal bovine serum, 2mM Lglutamine, containing 100 units/mL penicillin G sodium, 100 units/mL streptomycin sulfate, and 250 ng/mL amphotericin B. Cells were maintained at subconfluency at 37 ºC in humidified air containing 5% CO 2 . Tested compounds were dissolved in an equal mixture of DMSO (99.9% HPLC grade; Aldrich) and 95% ethanol at concentrations 1000-fold higher than the final concentrations. The results were compared with cells treated with this solvent at a corresponding concentration. For sub-culturing, monolayer cells were harvested after trypsin/EDTA treatment at 37 °C, except RAW 264.7 cells, which were collected by scraping. Cells were used after confluence had reached 75%. Cells treated with the corresponding concentration of DMSO were used as a control group. All experiments were repeated four times and the data were represented as the mean values of these experiments.
Anti-tumor assay: Cytotoxicity against various tumor cell lines was estimated by the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay, according to Mosmann [20] . Cells of different tumor cell lines were seeded in a 96 well plate at a concentration of 5x10 4 cells/well and incubated overnight. After treatment with various concentrations of the compounds (0, 10, 20, 40 and 80 µM, respectively), cells were incubated for an additional 24 h at 37ºC in a serum-free medium. During the last 4 h, cells were incubated with 40 µL of MTT stock solution (5 mg/mL) at 37ºC. Samples were then extracted with 100 µL acidic isopropanol and the absorbance was measured with the ELISA reader (BioRad, USA) at 570 nm. The relative cell viability was determined by the amount of MTT converted to the insoluble formazan salt. The data are expressed as the mean percentage of viable cells as compared to the respective control cultures treated with the solvent.
Macrophage proliferation assay:
The macrophage proliferation index also was investigated using the MTT assay. RAW 264.7 cells were seeded in a 96 well plate at a concentration of 3 x 10 4 cells / well and incubated for 24 h at 37 ºC in serum free medium with the mentioned concentrations of the compounds. The cells were incubated for 6 h with 40 µL of MTT (5 mg/mL) at 37 ºC, before adding 100 µL acidic isopropanol. The absorbance was measured at 570 nm with the ELISA reader. The macrophage proliferation index was calculated as follows:
Proliferation index = [(A compound / A control ) -1] x100, where A is the absorbance.
Nitrite assay: The accumulation of nitrite was measured in the culture medium by the Griess reaction according to Ding et al [21] . RAW 264.7 cells were grown in a 6-well plate in a phenol red free-RPMI medium containing 10% fetal bovine serum. Cells were incubated for 2 h with different compounds at a concentration of 20 µM before being incubated either with or without bacterial lipopolysaccharide (LPS, 1µg/mL) for another 20 h. In brief, 50µL of cell culture medium was mixed with 50µL Griess reagent [equal volumes of 1% (w/v) sulfanilamide in 5% (v/v) phosphoric acid and 0.1% (w/v) naphtylethylenediamine-HCl]. The mixture was incubated at room temperature for 10 min, and the absorbance at 540 nm measured with a microplate reader. Fresh culture medium was used as the blank in all experiments. A standard curve was plotted using serial concentrations of freshly prepared sodium nitrite in the culture medium, and the amount of nitrite in the samples was calculated.
Antioxidant activity:
The antioxidant capacity of the tested compounds was studied through their scavenging activity against 1,1-diphenyl-2-picrylhydrazyl (DPPH) radicals, using the method of Gerhauser et al. [22] .
